That is very important, since the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (korean actress). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're created to do. This was a breakthrough almost nobody discovered. However it's going to have extensive ramifications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment chances in this space, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (first lady). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially before going greater - jeff brown prediction. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. However that's not the big concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. genetic sequencer stock jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of excellent personal business on the verge of hitting the public markets And I've been dealing with a brand-new way for you to invest even prior to these business go public.
This chance has actually been developing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your area for complimentary.
Emma Walsh here, managing editor of the Diary. Regular Diary readers know that tech isn't our typical beat (jeff brown top stock pick 2021). And when it concerns tech investing, we leave it to the experts. Thankfully, we have several such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we understand (korean actress). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing exponential development and creating incredible opportunities for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown biotech pick. However despite what many readers might believe, this is a trend that's just getting begun. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown biotech genome sequencing). Losing 2 months of manufacturing and sales truly affects how many 5G devices are sold in the calendar year. When you consider all of that, selling 250 million units is exceptional. More notably, the hold-ups triggered by the pandemic developed a lot of pent-up demand. And that demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown 2021 predictions. And that's not my only 5G forecast When I've talked about 5G in the past, I've described its three various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services begin to be provided (last year). That's when we begin to see applications working on 5G networks. Think about things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summertime. This starts something of a virtuous cycle: Many people do not really care about the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open a suite of extraordinary applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be enormous. Stepping away from 5G, the next crucial technology I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For several years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were actually only 3 business running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing unbelievable returns. This whole market is efficiently a greenfield opportunity.
There's room for lots of business to exist in this space. jeff brown tech stock 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or three more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can accurately predict the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is necessary because the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced utilizing this technology. This was among those developments that almost no one observed. But it's going to have profound implications for treating disease. And, obviously, there will be a lot of investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially before going greater. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever released was on bitcoin - last year. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown biotech stocks. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date as of February 2021, however we could not separately confirm this claim. Provided Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like ability to pick winning technology stocks. He invested more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an exceptional viewpoint on the market. He's constantly on the hunt for new opportunities, and he shares numerous of his finest choices in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully forecasted a few of the biggest economic events of the past 20 years. Although he doesn't appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, however Jeff Brown's precise predictions have made him legions of devoted fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a popular monetary research publisher. Brownstone Research provides numerous research study services with a variety of specializations - jeff brown biotech pick.
The company is also affiliated with Bonner & Partners, another well-respected research publisher - jeff brown investor prediction. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research study: "For too long, the finest investment research study has actually not been offered to individual financiers. It has actually been generally booked for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown latest prediction. The objective of Brownstone Research is to make that type of exclusive research offered to any investors looking to get an edge in the markets. The objective is simple to deliver unique and rewarding financial investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise acts as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. second wave. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown believes S.A.V. jeff brown biotech pick. might be "the biggest trend of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two cutting-edge innovations: expert system and electric cars and trucks. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the automobile market's Holy Grail. As you know, electric cars and self-driving car stocks have been huge this year, however the Wall Street machine has approved hype without much concrete result. Regardless of a drastic boost in competitors over the previous few years, Brown still believes Musk has the best chance of putting everything together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Automobile, and it might be the future of transport. Basically, this innovation would allow you to rent your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the revenues. It sounds outrageous, however it could be closed than you think.